You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MEK162

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • MEK162
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

Active, not recruiting
  • Low-Grade Gliomas
  • +2 more
  • MEK162
  • Birmingham, Alabama
  • +14 more
Jan 25, 2023

Lung Cancer Trial in Boston (Binimetinib, Palbociclib)

Recruiting
  • Lung Cancer
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Solid Tumors Harboring a BRAF V600 Mutation Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Solid Tumors Harboring a BRAF V600 Mutation
  • Tampa, Florida
  • +22 more
Mar 16, 2022

Leukemia Trial in Houston (MEK 162)

Terminated
Has Results
  • Leukemia
  • MEK 162
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2021

Gastrointestinal Stromal Tumor (GIST) Trial in New York (MEK162, Pexidartinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 29, 2021

Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

Recruiting
  • Colorectal Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 11, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

BRAF or NRAS Mutant Metastatic Melanoma Trial in Worldwide (MEK162)

Active, not recruiting
Has Results
  • BRAF or NRAS Mutant Metastatic Melanoma
  • MEK162
  • Fayetteville, Arkansas
  • +20 more
Nov 18, 2021

Lungcancer Trial in Canada (Binimetinib, Pemetrexed, Carboplatin)

Completed
  • Lungcancer
  • Edmonton, Alberta, Canada
  • +3 more
Apr 1, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • (no location specified)
Nov 8, 2022

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • (no location specified)
Nov 8, 2022

Advanced Biliary Tract Carcinoma Trial in New York (Gemcitabine, Cisplatin, MEK162)

Completed
Has Results
  • Advanced Biliary Tract Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2020

Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma Trial in Guangzhou (BYL719, INC280, LDK378)

Completed
Has Results
  • Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma
  • Guangzhou, Guangdong, China
    Novartis Investigative Site
Nov 20, 2020

Metastatic Colorectal Cancer Trial in Worldwide (MEK162, Panitumumab)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Los Angeles, California
  • +7 more
Jan 27, 2021

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Advanced Solid Tumor Trial in Nagoya-city, Yufu (MEK162)

Completed
  • Advanced Solid Tumor
  • MEK162
  • Nagoya-city, Aichi, Japan
  • +1 more
Sep 30, 2020

Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 14, 2021

Cardiomegaly Trial in Boston, London (MEK162)

Withdrawn
  • Cardiomegaly
  • MEK162
  • Boston, Massachusetts
  • +1 more
Oct 2, 2020

Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)

Active, not recruiting
  • Metastatic Melanoma
  • Salzburg, AT, Austria
  • +29 more
Feb 23, 2022

Metastatic Pancreatic Adenocarcinoma, BRAF Mutated Melanoma Trial in Worldwide (MEK162, AMG 479)

Terminated
  • Metastatic Pancreatic Adenocarcinoma
  • BRAF Mutated Melanoma
  • MEK162
  • AMG 479
  • Boston, Massachusetts
  • +8 more
Dec 9, 2020

Hepatic Impairment Trial in United States (MEK162)

Terminated
  • Hepatic Impairment
  • MEK162
  • Lakewood, Colorado
  • +4 more
Sep 16, 2020